← Leaderboards
E Aubrey Thompson
University Of Texas Medical Br Galveston
$2,793,172
Attributed
$3,222,445
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $443.3K · FY2006–23$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,222,445 · 7
By mechanism
R01$1,794,333 · 1
R21$736,619 · 2
R03$455,796 · 3
R24$235,697 · 1
Top collaborators
- Nicole R Murray2 shared
- Brian M Necela2 shared
- Michael Bradley Wallace2 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Ayman Al-Hendy$16,587,078
- Alan P Fields$16,541,191
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCohortStagingGene ExpressionCell CycleEpithelial CellsMessenger RnaCellsPropertyApoptosisColonProtocols DocumentationGenesCancer CellMalignant NeoplasmsLinkHormone Regulation /Control MechanismLymphomaMediatingEventChemopreventive AgentColon CarcinomaDexamethasoneBcl2 Gene /Protein
Grant awards (16)
Implementation of automated staining in conjunction with spatial analyses$235,697
R24 · FY2023 · OD · contact PI
MicroRNAs in lobular involution and breast cancer$168,563
R21 · FY2012 · CA · contact PI
Chemopreventive signaling pathways$77,500
R03 · FY2012 · CA · contact PI
MicroRNAs in lobular involution and breast cancer$202,275
R21 · FY2011 · CA · contact PI
Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases$163,506
R21 · FY2011 · CA · contact PI
Chemopreventive signaling pathways$77,500
R03 · FY2011 · CA · contact PI
Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases$202,275
R21 · FY2010 · CA · contact PI
PPAR-gamma regulation of micro RNA metabolism in colon cancer$75,500
R03 · FY2008 · CA · contact PI
PPAR-gamma regulation of micro RNA metabolism in colon cancer$75,500
R03 · FY2007 · CA · contact PI
Chemoprevention of colitis-associated colon cancer$73,796
R03 · FY2007 · CA · contact PI
Chemoprevention of colitis-associated colon cancer$76,000
R03 · FY2006 · CA · contact PI
HORMONAL CONTROL OF PROLIFERATION$380,391
R01 · FY2004 · CA
HORMONAL CONTROL OF PROLIFERATION$369,309
R01 · FY2003 · CA
HORMONAL CONTROL OF PROLIFERATION$358,554
R01 · FY2002 · CA
HORMONAL CONTROL OF PROLIFERATION$348,110
R01 · FY2001 · CA
HORMONAL CONTROL OF PROLIFERATION$337,969
R01 · FY2000 · CA